Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

EQL Pharma invites to Capital Markets Day, March 7, 2025

EQL Pharma

EQL Pharma AB (publ), a leading Niche Pharmaceuticals Company, is pleased to invite investors and other interested parties to a Capital Markets Day (CMD) on Friday, March 7, 2025.

During the day EQL Pharma's CEO Axel Schörling, Chief Commercial Officer Alexander Brising and Chief Business Development Officer Carl Lindgren will give an updated investor presentation. The presentations will be held in English.

During the presentation, EQL will share its new long term financial targets and strategic plan with a special focus on how the company plans to reach these new targets. Additionally, the Business Development, Sales and M&A approaches will be covered in more detail as well as the key strategic assets Mellozzan and Memprex.

The event will be held at Carnegie's premises in Stockholm, Sweden and a live webcast will be available for those who cannot attend in person.

Location: Regeringsgatan 56, 111 56 Stockholm
Date & Time: 7 March 2025, 09:00-12:00 CET

Registration: https://tinyurl.com/bddzbxnh

It will be possible to ask questions both from the audience and via webcast during the presentations.

For inquiries regarding one-on-one meetings or other event-related questions, kindly send an email to ellen.mioen@carnegie.se.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.